Literature Monitoring in Pharmacovigilance: A Practical Guide

Adverse events do not only arrive as direct reports — many are first described in published case reports, studies, and journal articles. That is why regulators require marketing authorisation holders to monitor the scientific literature and to capture valid cases found there. This guide explains what literature monitoring involves, the obligations behind it, and how modern software reduces the heavy manual effort it traditionally requires.

#Why literature monitoring is required

Under EU GVP Module VI and equivalent expectations elsewhere, companies must conduct systematic literature reviews to identify Individual Case Safety Reports and other safety-relevant information about their products. Cases found in the literature are subject to the same reporting obligations and timelines as any other valid ICSR. Missing a reportable case in the literature is a genuine compliance and patient-safety risk.

#The literature monitoring workflow

1. Define and run searches

It starts with a documented search strategy against literature databases — typically PubMed/MEDLINE and Embase — plus relevant local journals. Searches are scheduled (often weekly) and the exact strategy is recorded for audit purposes.

2. Screen and triage results

Each search returns far more articles than are relevant. Screening filters out duplicates and previously-reviewed articles, then triages the rest for relevance. This is the most time-consuming step, and the one where AI-assisted relevance triage has the biggest impact.

3. Assess for valid ICSRs

A reviewer assesses the relevant articles to decide whether each describes a valid ICSR — an identifiable patient, reporter, suspect product, and event. AI can flag likely valid ICSRs, but a human reviewer confirms the determination.

4. Article-to-case and reporting

Qualifying articles are converted into structured ICSRs and flow into the normal case processing workflow, with the source article retained. From there the case follows the usual coding, assessment, and submission path.

#The challenges teams face

• Volume — searches surface large numbers of articles, most irrelevant
• Duplicates — the same article appears across databases and search runs
• Consistency — screening decisions must be applied uniformly and documented
• Auditability — the search strategy, screening decisions, and reviewer sign-off all need an audit trail
• Timeliness — valid cases must still be reported within standard deadlines

#How AI-assisted monitoring helps

Modern platforms automate the mechanical parts of this workflow. Scheduled searches run automatically; duplicate and previously-reviewed detection removes noise; AI-assisted screening ranks articles by relevance and flags likely ICSRs for confirmation; and full-text retrieval plus annotation keeps reviewers efficient. Crucially, the reviewer remains the decision-maker — AI narrows the pile, people make the call.

PVgenix includes literature monitoring with scheduled searches, automated screening and relevance triage, AI-assisted identification of valid ICSRs (with human confirmation), article-to-case conversion, duplicate detection, and a full audit trail. See the Literature Monitoring platform page for the full capability set.